Calcitriol down-regulates human ether à go-go 1 potassium channel expression in cervical cancer cells

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2667-2672

  Avila, Euclides ^a,b   García Becerra, Rocío ^a   Rodríguez Rasgado, Jesús Adrián ^b   Díaz, Lorenza ^a   Ordaz Rosado, David ^a   Zügel, Ulrich ^c   Steinmeyer, Andreas ^c   David, Barrera ^a   Ali, Halhali ^a   Fernando, Larrea ^a   Javier, Camacho ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c BAYER PHARMA AG   (Germany)

Author keywords

Calcitriol; Cervical cancer; EAG1; Placenta; Potassium channels; Prostate cancer; Vitamin D

Indexed keywords

CALCITRIOL; CYTOCHROME; MESSENGER RNA; POTASSIUM CHANNEL HERG; PROTEIN CYP27B1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TYPE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG DETERMINATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; MAMMARY GLAND; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 77955816248     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pardo LA, Del Camino D, Sánchez A, Alves F, Brüggemann A, Beckh S and Stühmer W: Oncogenic potential of EAG K+ channels. EMBO J 18: 5540-5547, 1999.
2. Occhiodoro TL, Bernheim L, Liu JH, Bijlenga P, Sinnreich M, Bader CR and Fischer-Lougheed J: Cloning of a human ether à go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett 434: 177-182, 1998. (Pubitemid 28404684)
3. Hemmerlein B, Weseloh RM, De Queiroz FM, Knotgen H, Sánchez A, Rubio ME, Martin S, Schliephacke T, Jenke M, Joachim RH, Stühmer W and Pardo LA: Overexpression of EAG1 potassium channels in clinical tumours. Mol Cancer 5: 41, 2006.
4. Farías LM, Ocaña DB, Díaz L, Larrea F, Avila-Chavez E, Cadena A, Hinojosa LM, Lara G, Villanueva LA, Vargas C, Hernandez-Gallegos E, Camacho-Arroyo I, Dueñas-González A, Pérez-Cárdenas E, Pardo LA, Morales A, Taja-Chayeb L, Escamilla J, Sánchez-Peña C and Camacho J: Ether à go-go potassium channels as human cervical cancer markers. Cancer Res 64: 6996-7001, 2004.
5. Ousingsawat J, Spitzner M, Puntheeranurak S, Terraciano L, Tornillo L, Bubendorf L, Kunzelmann K and Schreiber R: Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 13: 824-831, 2007. (Pubitemid 46340355)
6. Gavrilova-Ruch O, Schönherr K, Gessner G, Schönherr R, Klapperstuck T, Wohlrab W and Heinemann SH: Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells. J Membr Biol 188: 137-149, 2002. (Pubitemid 34804258)
7. + channel, Receptors and Channels 7: 345-356, 2001. (Pubitemid 32970633)
8. Weber C, De Queiroz FM, Downie BR, Suckow A, Stühmer W and Pardo LA: Silencing the activity and proliferative properties of the human EAG1 potassium channel by RNA interference. J Biol Chem 281: 13030-13037, 2006. (Pubitemid 43855212)
9. Gómez-Varela D, Zwick-Wallasch E, Knotgen H, Sánchez A, Hettmann T, Ossipov D, Weseloh R, Contreras-Jurado C, Rothe M, Stühmer W and Pardo LA: Monoclonal antibody blockade of the human EAG1 potassium channel function exerts antitumor activity. Cancer Res 67: 7343-7349, 2007.
10. Díaz L, Ceja-Ochoa I, Restrepo-Angulo I, Larrea F, Avila-Chavez E, García-Becerra R, Borja-Cacho E, Barrera D, Ahumada E, Gariglio P, Alvarez-Ríos E, Ocádiz-Delgado R, García-Villa E, Hernández-Gallegos E, Camacho-Arroyo I, Morales A, Ordaz-Rosado D, García-Latorre E, Escamilla J, Sánchez-Peña LC, Saqui-Salces M, Gamboa-Domínguez A, Vera E, Uribe-Ramírez M, Murbartián J, Ortiz CS, Rivera-Guevara C, De Vizcaya-Ruiz A and Camacho J: Estrogens and human papilloma virus oncogenes regulate human ether à-go-go-1 potassium channel expression. Cancer Res 69: 3300-3307, 2009.
11. García-Becerra R, Díaz L, Camacho J, Barrera D, Ordaz-Rosado D, Morales A, Ortiz CS, Avila E, Bargallo E, Arrecillas M, Halhali A and Larrea F: Calcitriol inhibits ether à go-go potassium channel expression and cell proliferation in human breast cancer cells. Exp Cell Res 316: 433-442, 2010.
12. Meyer R and Heinemann SH: Characterization of an eag-like potassium channel in human neuroblastoma cells. J Physiol (Lond.) 508: 49-56, 1998. (Pubitemid 28167569)
13. 2+/calmodulin. EMBO J 19: 3263-3271, 2000. (Pubitemid 30428204)
14. Dixon KM and Mason RS: Vitamin D. Intl J Biochem Cell Biol 41: 982-985, 2009.
15. Deeb KK, Trump DL and Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7: 684-700, 2007.
16. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W and Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Rec Res Cancer Res 164: 239-246, 2003.
17. 3 and cyclic AMP in cultured human syncytiotrophoblasts. J Ster Biochem Mol Biol 103: 90-96, 2007.
18. Avila E, Díaz L, Barrera D, Arranz C, Halhali A and Larrea F: Metabolism of vitamin D in the human choriocarcinoma cell line JEG-3. J Ster Biochem Mol Biol 103: 781-785, 2007. (Pubitemid 46420526)
19. 3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. J Biol Chem 275: 16506-16512, 2000. (Pubitemid 30398873)
20. Borowiec AS, Hague F, Harir N, Guenin S, Guerineau F, Gouilleux F, Roudbaraki M, Lassoued K and Ouadid-Ahidouch H: IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. J Cell Physiol 212: 690-701, 2007.
21. Fleet JC: Molecular actions of vitamin D contributing to cancer prevention. Mol Asp Med 29: 388-396, 2008.
22. Murayama A, Kim MS, Yanagisawa J, Takeyama K and Kato S: Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J 23: 1598-1608, 2004. (Pubitemid 38579520)
23. 3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol 21: 334-342, 2007.
24. McLaughlin-Drubin ME and Munger K: Oncogenic activities of human papillomaviruses, Virus Res 143: 195-208, 2009.
25. 3. Mol Endocrinol 7: 1307-1312, 1993.
26. Li XY, Boudjelal M, Xiao JH, Peng ZH, Asuru A, Kang S, Fisher GJ and Voorhees JJ: 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol 13: 1686-1694, 1999.
27. Deng C, Ueda E, Chen KE, Bula C, Norman AW, Luben RA and Walker AM: Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Mol Endocrinol 23: 226-236, 2009.